Calcium carbonate

Generic name
Calcium carbonate
Brand name
ATC Code
A12AA04

Calcium carbonate

Dosages
Side effects in children
Warnings & precautions in children
Contra-indications in children

Interactions
PK
Renal impairment
References

Pharmacokinetics in children

No information

dose recommendation of formulary compared to licensed use (on-label versus off-label)

No information is present at this moment.

Available formulations

No information is present at this moment.

Dosages

Calcium deficiency
  • Oral
    • 1 month up to 18 years
      • Calciumcarbonate: 50 - 100 mg/kg/day in 3 doses. Max: 12 g/day.
        Corresponding to: Elemental calcium (Ca2+):

        - 20-40 MG/kg/day max. 4,8 g/day
        - 0,499 – 0,998 MMOL/kg/day, max. 119,76 mmol/day.
        • Dependent on the diet (calcium/phosphate intake).
    • 1 month up to 18 years
      [2]
      • Depending on the plasma concentrations: 50 - 100 mg/kg/day in 3 doses. Max: 12 g/day.
        • Dependent on the diet (calcium/phosphate intake).
        • Depending on the serum concentrations of calcium and phosphate

Renal impaiment in children > 3 months

GFR ≥10 ml/min/1.73m2: Dose adjustment not required.

GFR <10 ml/min/1.73m2: A general recommendation on dose adjustment cannot be provided.

The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here

Side effects

No information is present at this moment.

The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here

Contra-indications

No information available on specific contra indications in children.

The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here

Warnings & precautions in children

In the case of mild hypercalciuria (exceeding 0.12 - 0.015 mmol or 4.8-0.6 mg / kg / 24 hours in children), in renal insufficiency and in nephrolithiasis carefully control the excretion of calcium and phosphate in the urine; in the case of increased excretion, the dosage must be reduced or the calcium therapy discontinued [SmPC].

Interactions

The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here

CALCIUM

This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.

Calcium
A12AA06
Calcium, combinations with vitamin D and/or other drugs
A12AX
CALCIUM
A12AA06
Calcium, combinations with vitamin D and/or other drugs
A12AX

References

  1. Rademaker C.M.A. et al, Geneesmiddelen-Formularium voor Kinderen, 2007
  2. Heijden, van der AJ et al, Werkboek Kindernefrologie, VU Uitgeverij, 2002, 1e druk

Changes

Therapeutic Drug Monitoring


Overdose